MedPath

Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass

Conditions
Acute Respiratory Distress Syndrome After Cardiac Surgery Under Cardiopulmonary Bypass
Registration Number
NCT01723930
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Get a better understanding of the pathophysiological processes of acute respiratory failure following cardiopulmonary bypass to initiate timely therapies targeted on a cell line.

Demonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patient man or woman > 18 y.o.

  • Patient has signed informed consent prior to the study

  • Patient affiliated to a social security administration

  • Patient operated on for cardiac surgery at the University Hospital of Strasbourg.

  • Patient at high risk for postoperative respiratory failure defined by a SLIP score (Kor et al.) ≥ 22 Kor:

    • High-risk cardiac intervention under cardiopulmonary bypass (19 pts)
    • COPD (10 pts)
    • Diabetes (6 pts)
    • gastroesophageal reflux (7 pts)
    • Alcohol abuse (11 pts)
  • Scheduled use of a pulmonary artery catheter and a left atrial catheter

Exclusion Criteria
  • Inability to obtain informed consent from the patient and / or unable to give informed patient information (difficulty understanding ...)
  • Urgent surgery (<24h)
  • Acute heart failure
  • Patient ventilated preoperatively
  • Allergy to Latex
  • Persons deprived of liberty or under judicial protection
  • Patient placed under guardianship
  • Pregnancy
  • Breastfeeding

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistanceduring the surgery

Demonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital

🇫🇷

Strasbourg, Alsace, France

University Hospital
🇫🇷Strasbourg, Alsace, France
Julien POTTECHER, MD
Principal Investigator
Mircea Cristinar, MD
Sub Investigator
Ghaib Ajob, MD
Sub Investigator
Anne Roche, MD
Sub Investigator
Matthieu Zappaterra, MD
Sub Investigator
Adrien Thibaud, MD
Sub Investigator
Wim Skibba, MD
Sub Investigator
Jean-Claude Thiranos, MD
Sub Investigator
François Levy, MD
Sub Investigator
Olivier Collange, MD
Sub Investigator
Sandrine Marguerite, MD
Sub Investigator
Jean-Paul Schmitt, MD
Sub Investigator
Hubert Gros, MD
Sub Investigator
Anne-Lise Maechel, MD
Sub Investigator
Paul-Michel Mertes, MD
Sub Investigator
Giedrius Laurinenas, MD
Sub Investigator
Amir Samet, MD
Sub Investigator
Cécile Gros, MD
Sub Investigator
Annick Steib, PhD
Sub Investigator
Pierre Diemunsch, PhD
Sub Investigator
Michel Kindo, MD
Sub Investigator
Jean-Philippe Mazzucotelli, PhD
Sub Investigator
Matthieu Canuet, MD
Sub Investigator
Max Guillot, MD
Sub Investigator
Vincent Castelain, PhD
Sub Investigator
Bernard Geny, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.